CIK 0001472091
- Non-accelerated filer
- Smaller reporting company
PDS Biotechnology Corp
Sign in to watch- Ticker
- PDSB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 264231384
- Phone
- +1 800-208-3343
- Business address
- 303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- Edge Therapeutics, Inc.
- 4 Open-market sale President and CEO sold 1,500 shares at $9.52 ($14,280)
- 4 Open-market sale President and CEO sold 3,000 shares at an average $9.61 ($28,815)
- 4 Open-market sale President and CEO sold 3,000 shares at an average $9.50 ($28,485)
- 4 Exercise or conversion Chief Scientific Officer acquired 25,000 shares (option exercise)
- 4 Open-market sale President and CEO sold 7,500 shares at $11.60 ($87,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President and CEO sold 7,500 shares at $10.25 ($76,844)
- 4 Open-market buy Senior VP, GC and Secretary bought 10,000 shares at an average $9.48 ($94,793)
- 4 Open-market sale President and CEO sold 7,500 shares at $9.54 ($71,582)
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 12 of 14 · 278 filings